Clinical Trials Sponsored by Avanir Pharmaceuticals

Total 19615 results

Avanir Pharmaceuticals

Completed

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Alzheimer's Disease | Agitation

United States
Avanir Pharmaceuticals

Completed

Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants

Healthy Adult Male and Female Volunteers

United States
Avanir Pharmaceuticals

Terminated

Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Pseudobulbar Affect (Involuntary Laughing and/or Crying)

United States
Avanir Pharmaceuticals

Completed

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura (COMPASS)

Migraine | Headaches

United States
Avanir Pharmaceuticals

Completed

Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy

Pain | Diabetic Neuropathy

United States
Avanir Pharmaceuticals

Completed

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Stroke | Parkinson's Disease | Traumatic Brain Injury | Alzheimer's Disease

United States
Avanir Pharmaceuticals

Completed

Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers

Healthy

Australia
Avanir Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Depressive Disorder, Treatment-Resistant

United States
Avanir Pharmaceuticals

Completed

Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts (DDI)

Healthy

United States
Avanir Pharmaceuticals

Completed

Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients

Multiple Sclerosis

United States
Avanir Pharmaceuticals

Completed

A Phase 1 Study Comparing AVP-786 With AVP-923

Healthy Volunteer

United States
Avanir Pharmaceuticals

Completed

A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers

Healthy

Australia
Avanir Pharmaceuticals

Completed

PRISM Registry: Pseudobulbar Affect Registry Series

Stroke | Parkinson's Disease | Traumatic Brain Injury | Amyotrophic Lateral Sclerosis (ALS) | Alzheimer's Disease | Multiple Sclerosis (MS)

United States
Avanir Pharmaceuticals

Completed

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis (PRIME)

Multiple Sclerosis | Central Neuropathic Pain

United States, Spain, Czechia, Poland, Argentina
Avanir Pharmaceuticals

Terminated

Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition

Disinhibition Syndrome

United States
Avanir Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia

Schizophrenia

United States
Avanir Pharmaceuticals

Completed

Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) (PRISM II)

Stroke | Dementia | Traumatic Brain Injury (TBI) | Pseudobulbar Affect (PBA)

United States
Avanir Pharmaceuticals

Completed

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Amyotrophic Lateral Sclerosis

United States
Avanir Pharmaceuticals
Syneos Health

Completed

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (STAR)

Pseudobulbar Affect (PBA)

United States, Argentina, Brazil
Cady, Roger, M.D.
Avanir Pharmaceuticals

Completed

Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine

Episodic Migraine

United States
St. Joseph's Hospital and Medical Center, Phoenix
Avanir Pharmaceuticals

Terminated

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

Alzheimer's Disease | Pseudobulbar Affect (PBA)

United States
Avanir Pharmaceuticals
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (LID in PD)

Parkinson's Disease | Dyskinesia

Canada, United States
OrbusNeich
Avania

Not yet recruiting

Sapphire 3 CTO Study

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Chronic Total Occlusion | Chronic Total Occlusion of Coronary Artery
Cochlear
Avania

Not yet recruiting

Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users (RECONNECT)

Hearing Loss, Conductive | Hearing Loss, Mixed Conductive-Sensorineural

Australia
ONY
Avania

Not yet recruiting

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS (Aero-05)

Intubation Complication | Death; Neonatal | Respiratory Distress Syndrome (Neonatal)

United States
Cochlear
Avania

Not yet recruiting

Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implant Recipients (DUAL)

Hearing Loss, Sensorineural

Australia
Cochlear
Avania

Recruiting

A Study Evaluating the Application of Hearing Aid Technologies to Signal Processing for Adult Cochlear Implant Recipients (HATSI-MB)

Hearing Loss

Australia
Cochlear
Avania

Completed

Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients. (PINNA)

Adult Cochlear Implant Recipients

Australia
Cochlear
Avania

Completed

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients (POLAR) (POLAR)

Hearing Impairment

Australia
Cochlear
Avania

Completed

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

Hearing Impairment, Sensorineural

Australia
Cochlear
Avania

Completed

CP1110 Sound Processor Feasibility

Adult Cochlear Implant Recipients

Australia
Ladera Medical
Avania

Not yet recruiting

The Ladera Large Bore Closure Feasibility Study

Vascular Closure | Femoral Arteriotomy Closure
Evolus, Inc.
Avania

Recruiting

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Glabellar Frown Lines

Germany
LeMaitre Vascular
Avania

Recruiting

A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters (OTW)

Thrombus | Embolus | Occlusion; Vessel

Germany, Switzerland
LeMaitre Vascular
Avania

Recruiting

Post-Market Registry in Europe and US for the Use of VascuCelTM (VascuCel)

Great Vessel Reconstruction | Peripheral Vessel Reconstruction | Suture Line Buttressing

United States, Italy
Abionic SA
Avania

Completed

abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003 (AB-PSP-007)

Sepsis

United States
WhiteSwell, Limited
Avania

Completed

Safety and Feasibility of the WhiteSwell System" (SWIFTHF)

Heart Failure | Congestive Heart Failure

United States
Lumendo AG
Avania

Not yet recruiting

A Study to Assess the Clinical Success of Root Canal Treatment Using Novel Obturation Material.

Endodontic Treatment

Turkey
LeMaitre Vascular
Avania

Recruiting

A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter (SLC)

Arterial Thromboembolism

Belgium, Germany, Switzerland
Abionic SA
Avania

Completed

Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis

Sepsis

United States
Azura Ophthalmics
Avania

Completed

Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)

Contact Lens Discomfort

Australia
Azura Ophthalmics
Avania

Completed

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Meibomian Gland Dysfunction

Australia, New Zealand
Boa Biomedical, Inc.
Avania

Recruiting

GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection

Bloodstream Infection

United States
Fuji Systems Corporation
Avania

Active, not recruiting

Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair

Aortic Aneurysm | Aortic Dissection | Aortic Arch Aneurysm | Aortic Arch; Aneurysm, Dissecting

Germany, Netherlands
Integra LifeSciences Corporation
Avania

Completed

CERTAS Programmable Valve Registry (CERTAS)

Hydrocephalus | NPH (Normal Pressure Hydrocephalus) | IIH - Idiopathic Intracranial Hypertension

Germany, Netherlands
Creo Medical Limited
Avania

Recruiting

Bronchoscopic Microwave Ablation of Lung Tissue (AB1MALT)

Lung Cancer

United Kingdom
Cochlear
Avania; QbD Clinical

Recruiting

Speech Performance and Clinic Efficiency With Remote Care Compared With Standard of Care in Adults With a Cochlear Implant in the First 12 Months Post-activation (INSPIRE)

Hearing Loss

Belgium, United Kingdom, Italy, Netherlands
ATRO Medical B.V.
Avania

Recruiting

AIR (Artificial Implant to Restore the Medial Meniscus Function)2 Clinical Investigation (AIR2)

Knee Injuries and Disorders

Netherlands
Orthox Limited
Avania B.V.

Terminated

FibroFix Cartilage P Knee Implant Study (FFLEX)

Osteoarthritis, Knee

United Kingdom, Hungary
Cochlear
Avania; QbD Clinical

Recruiting

Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation (CALOS4)

Hearing Loss

Germany, Australia

3

Subscribe